ReviewRSC advances2025
Photothermal applications of upconversion nanoparticles.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Revisiting the potential of upconversion nanoparticles in biomedical applications: Advances and emerging perspectives.Materials today. Bio · 2026Review
- Preparation Method of Upconversion Nanoparticles and Its Biological Application.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upconversion nanoparticles (UCNPs) have become a versatile nanoplatform with promising potential in photothermal applications. By efficiently converting near-infrared (NIR) light into heat, UCNPs offer a non-invasive approach to induce hyperthermia in specific target tissues, such as cancer cells, while preserving surrounding healthy cells. The utilization of UCNPs in combination therapies, multifunctional nanosystems, and regenerative medicine applications highlights their versatility and adaptability in addressing complex healthcare challenges. By leveraging the multifunctionality of UCNPs, researchers can develop approaches for disease management, drug delivery, and monitoring, opening the path for more effective and tailored biomedical interventions. However, challenges such as NIR light penetration limitations, biocompatibility considerations, photothermal conversion efficiency optimization, tumor targeting strategies, and clinical translation studies need to be carefully considered and overcome to maximize the efficacy of UCNPs in photothermal applications. We aim to provide an inclusive exploration of the potential applications of UCNPs in photothermal therapy, highlighting their unique properties and versatility in targeted therapeutic interventions. This review explores the photothermal conversion efficiency, tumor-targeting strategies, and future prospects of UCNPs, aiming to highlight the challenges and opportunities in employing these nanoparticles for precise and effective applications in cancer therapy, tissue engineering, and personalized medicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.